FDA Authorizes InBios SCoV-2 Ag Detect Rapid Self-Test

InBios SCoV-2 Ag Detect Rapid Self-Test delivers results in about 20 minutes; available without a prescription

If your email program has trouble displaying this email, view as a webpage. FDA Authorizes InBios COVID-19 Over-the-Counter Antigen Test The U.S. Food and Drug Administration (FDA) authorized another over-the-counter (OTC) COVID-19 antigen test. The FDA is committed to increasing the availability of appropriately accurate and reliable at-home COVID-19 diagnostic tests and to facilitating consumer access to these tests. The FDA issued an emergency use authorization (EUA) for the InBios SCoV-2 Ag Detect Rapid Self-Test, an OTC COVID-19 antigen diagnostic test that delivers results in about 20 minutes. The test can be used as: A single test for people with COVID-19 symptoms within the first five days of symptom onset. A serial test for people without symptoms, meaning the test is done two times over three days. The test can be used for people: Age 14 years or older with a self-collected nasal swab sample. Age 2 years or older when an adult collects the nasal swab sample. Read More Questions? If you have questions about OTC COVID-19 tests, see Coronavirus Disease 2019 Testing Basics.

Follow us on Twitter at @FDADeviceInfo Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA